Gledhill L, Williams P, Bycroft B W
Department of Pharmaceutical Sciences, University of Nottingham, U.K.
Biochem J. 1991 Jun 15;276 ( Pt 3)(Pt 3):801-7. doi: 10.1042/bj2760801.
On incubation of the chlorinated 6-spiroepoxypenicillin anilides (I) and (II) [formula: see text] with beta-lactamase 1 from Bacillus cereus, three distinct processes are observed. The inhibitors act as (a) substrates, the turnover of which respectively results in a single product, namely 6-substituted 2(H)-3,4-dihydro-1,4-thiazine, (b) a transiently inhibited enzyme complex, and finally (c) an irreversibly inactivated enzyme complex. Although differing only in their stereochemistry at one centre, the anilide (K) is a more potent irreversible inactivator of beta-lactamase I than is compound (II). Analysis of irreversibly inactivated beta-lactamase I by isoelectric focusing and inspection of peptide fragmentation maps indicated that irreversible inactivation appears to be accompanied by covalent modification. These studies reveal that the chlorinated 6-spiroepoxypenicillin anilide (I) is a mechanism-based beta-lactamase inhibitor.
将氯化的6-螺环氧青霉素酰苯胺(I)和(II)[化学式:见原文]与蜡状芽孢杆菌的β-内酰胺酶1一起温育时,观察到三个不同的过程。抑制剂表现为:(a)底物,其周转分别产生单一产物,即6-取代的2(H)-3,4-二氢-1,4-噻嗪;(b)瞬时抑制的酶复合物;最后(c)不可逆失活的酶复合物。尽管酰苯胺(K)和化合物(II)仅在一个中心的立体化学上有所不同,但酰苯胺(K)是比化合物(II)更有效的β-内酰胺酶I不可逆失活剂。通过等电聚焦分析不可逆失活的β-内酰胺酶I并检查肽片段图谱表明,不可逆失活似乎伴随着共价修饰。这些研究表明,氯化的6-螺环氧青霉素酰苯胺(I)是一种基于机制的β-内酰胺酶抑制剂。